Jim Simons In Med Pharmaceuticals Inc. Put Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INM
# of Institutions
19Shares Held
686KCall Options Held
0Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ362KShares$97,6664.44% of portfolio
-
Armistice Capital, LLC New York, NY267KShares$72,0810.0% of portfolio
-
Two Sigma Securities, LLC New York, NY15.4KShares$4,1640.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il12.7KShares$3,4350.0% of portfolio
-
Qube Research & Technologies LTD London, X0200Shares$540.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $245K
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...